Stay updated on Abaloparatide Long-Term Extension Clinical Trial
Sign up to get notified when there's something new on the Abaloparatide Long-Term Extension Clinical Trial page.

Latest updates to the Abaloparatide Long-Term Extension Clinical Trial page
- CheckyesterdayChange DetectedThe page has removed a citation regarding the effect of Abaloparatide vs Alendronate on fracture risk reduction in postmenopausal women with osteoporosis, including an erratum reference.SummaryDifference0.4%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect the latest version of the study protocol for the BA058-05-005 ACTIVExtend Trial, including changes in the study's masking description and the removal of previous study purpose details. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference12%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Abaloparatide Long-Term Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abaloparatide Long-Term Extension Clinical Trial page.